{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T03:20:11Z","timestamp":1780716011804,"version":"3.54.1"},"reference-count":61,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Science Progress"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:p>For decades, increasing incidence and prevalence of Crohn's disease (CD) have attracted more attention. Some severe complications such as perforations, fistulas, and abscesses have significantly impaired patients\u2019 quality of life. Though the emergence of biologic agents has improved disease course and prognosis to a great extent, different disease manifestations and the economic burden of disease make biologic agents not suitable for all CD patients. The ultimate goal of achieving clinical and endoscopic remission, and even transmural healing is same for every CD patient, but therapeutic decision is so difficult for individual differences. Making a personalized approach based on disease behavior, drug response and other related factors is critical for disease management. This review attempts to summarize the existing clinical trials and data for better tailoring personalized therapy of CD.<\/jats:p>","DOI":"10.1177\/00368504251341943","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T07:32:08Z","timestamp":1747726328000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Tailoring therapy to the individuals of Crohn's disease"],"prefix":"10.1177","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7198-0163","authenticated-orcid":false,"given":"Xin","family":"Gao","sequence":"first","affiliation":[{"name":"Renmin Hospital of Wuhan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Renmin Hospital of Wuhan University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32448-0"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31711-1"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2005.08.011"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318484"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2018.27"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2013.06.002"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000202"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izz104"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmn.2007.08.001"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.19"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.0b013e31823ccea8"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcg.0000177243.51967.ca"},{"key":"e_1_3_2_14_2","first-page":"263","article-title":"European Crohn's and colitis organisation topical review on IBD in the elderly","volume":"11","author":"Sturm A","year":"2017","unstructured":"Sturm A, Maaser C, Mendall M, et al. European Crohn's and colitis organisation topical review on IBD in the elderly. J Crohns Colitis 2017; 11: 263\u2013273. Consensus Development Conference; Journal Article.","journal-title":"J Crohns Colitis"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000978"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.06.070"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izy143"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12533"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.0709"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2008.155812"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1159\/000443134"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-303958"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2014.04.005"},{"key":"e_1_3_2_24_2","first-page":"15","article-title":"Treatment of active Crohn's disease in children using partial enteral nutrition combined with a modified Crohn's disease exclusion diet: a pilot prospective cohort trial on clinical and endoscopic outcomes","volume":"21","author":"Urlep D","year":"2023","unstructured":"Urlep D, Orel R, Kunstek P, et al. Treatment of active Crohn's disease in children using partial enteral nutrition combined with a modified Crohn's disease exclusion diet: a pilot prospective cohort trial on clinical and endoscopic outcomes. Nutrients 2023; 21: 15. Evaluation Study; Journal Article.","journal-title":"Nutrients"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-019-00672-x"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318484"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw168"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31711-1"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2023.05.051"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjae091"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/jeb.12721"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000433"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-024-00935-y"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/codi.14448"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00005.2021"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw169"},{"key":"e_1_3_2_37_2","first-page":"12","article-title":"Where are we and where to next?-the future of perianal Crohn's disease management","volume":"19","author":"Anandabaskaran S","year":"2023","unstructured":"Anandabaskaran S, Hanna L, Iqbal N, et al. Where are we and where to next?-the future of perianal Crohn's disease management. J. Clin Med 2023; 19: 12. Journal Article; Review.","journal-title":"J. Clin Med"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/1751-2980.12994"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw168"},{"key":"e_1_3_2_40_2","first-page":"415","article-title":"A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial","volume":"9","author":"Noor NM","year":"2024","unstructured":"Noor NM, Lee JC, Bond S, et al. A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial. Lancet Gastroenterol 2024; 9: 415\u2013427. Journal Article; Multicenter Study; Randomized Controlled Trial.","journal-title":"Lancet Gastroenterol"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32641-7"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.110"},{"key":"e_1_3_2_43_2","article-title":"Biomarkers predictive of response to thiopurine therapy in inflammatory bowel disease","volume":"7","author":"Cornish JS","year":"2020","unstructured":"Cornish JS, Wirthgen E, Dabritz J. Biomarkers predictive of response to thiopurine therapy in inflammatory bowel disease. Front Med-Lausanne 2020; 7: 1\u201311. Journal Article; Review.","journal-title":"Front Med-Lausanne"},{"key":"e_1_3_2_44_2","first-page":"1002","article-title":"Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis","volume":"6","author":"Singh S","year":"2021","unstructured":"Singh S, Murad MH, Fumery M, et al. Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis. Lancet Gastroenterol 2021; 6: 1002\u20131014. Comparative Study; Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Systematic Review.","journal-title":"Lancet Gastroenterol"},{"key":"e_1_3_2_45_2","first-page":"12","article-title":"Recent advances in the optimization of anti-TNF treatment in patients with inflammatory bowel disease","volume":"7","author":"Orfanoudaki E","year":"2023","unstructured":"Orfanoudaki E, Foteinogiannopoulou K, Theodoraki E, et al. Recent advances in the optimization of anti-TNF treatment in patients with inflammatory bowel disease. J. Clin Med 2023; 7: 12. Journal Article; Review.","journal-title":"J. Clin Med"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.12.031"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000001126"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izy044"},{"key":"e_1_3_2_49_2","article-title":"Ustekinumab in Crohn's disease: new data for positioning in treatment algorithm","volume":"16","author":"D'Amico F","year":"2022","unstructured":"D'Amico F, Peyrin-Biroulet L, Danese S. Ustekinumab in Crohn's disease: new data for positioning in treatment algorithm. J Crohns Colitis 2022; 16: ii30\u2013ii41. Journal Article; Review.","journal-title":"J Crohns Colitis"},{"key":"e_1_3_2_50_2","first-page":"13","article-title":"Ustekinumab or vedolizumab after failure of anti-TNF agents in Crohn's disease: a review of comparative effectiveness studies","volume":"8","author":"Sharip MT","year":"2024","unstructured":"Sharip MT, Nishad N, Pillay L, et al. Ustekinumab or vedolizumab after failure of anti-TNF agents in Crohn's disease: a review of comparative effectiveness studies. J. Clin Med 2024; 8: 13. Journal Article; Review.","journal-title":"J. Clin Med"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-024-00989-y"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.01.047"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe2301147"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-024-02130-x"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904492"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(04)00344-1"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20014"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.09.010"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2022.2045350"},{"key":"e_1_3_2_60_2","article-title":"Dual biologic therapy induces remission in refractory Crohn's disease with vedolizumab and ustekinumab","volume":"7","author":"Hassan SA","year":"2025","unstructured":"Hassan SA, Perry C, Carey P, et al. Dual biologic therapy induces remission in refractory Crohn's disease with vedolizumab and ustekinumab. Crohns Colitis 360 2025; 7: otae80. Journal Article.","journal-title":"Crohns Colitis 360"},{"key":"e_1_3_2_61_2","article-title":"Exploring dual-targeted therapy in the management of moderate to severe inflammatory bowel disease: a retrospective study","volume":"7","author":"Bhaskar S","year":"2025","unstructured":"Bhaskar S, Makovich Z, Mhaskar R, et al. Exploring dual-targeted therapy in the management of moderate to severe inflammatory bowel disease: a retrospective study. Crohns Colitis 360 2025; 7: otae57. Journal Article.","journal-title":"Crohns Colitis 360"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13460"}],"container-title":["Science Progress"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00368504251341943","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/00368504251341943","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00368504251341943","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:15:59Z","timestamp":1777634159000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/00368504251341943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10.1177\/00368504251341943"],"URL":"https:\/\/doi.org\/10.1177\/00368504251341943","relation":{},"ISSN":["0036-8504","2047-7163"],"issn-type":[{"value":"0036-8504","type":"print"},{"value":"2047-7163","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]},"article-number":"00368504251341943"}}